Allogene Therapeutics Inc., a South San Francisco-based company developing off-the-shelf allogeneic T-cell therapies for cancer, is taking a 25% stake in Notch Therapeutics Inc., paying the Canadian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback